Melanoma, version 2.2013: featured updates to the NCCN guidelines.

DG, Coit; R, Andtbacka; CJ, Anker; CK, Bichakjian; WE 3rd, Carson; A, Daud; D, Dimaio; MD, Fleming; V, Guild; AC, Halpern; FS Jr, Hodi; MC, Kelley; NI, Khushalani; RR, Kudchadkar; JR, Lange; A, Lind; MC, Martini; AJ, Olszanski; SK, Pruitt; MI, Ross; SM, Swetter; KK, Tanabe; JA, Thompson; V, Trisal; MM, Urist; N, McMillian; M, Ho

doi:10.6004/jnccn.2013.0055

Public

Melanoma, version 2.2013: featured updates to the NCCN guidelines.

Shared by NobleBlocks on Apr 1, 2013 • 12:00 AM UTC

Authors:

Coit DG

Andtbacka R

Anker CJ

Abstract

The NCCN Guidelines for Melanoma provide multidisciplinary recommendations on the clinical management of patients with melanoma. This NCCN Guidelines Insights report highlights notable recent updates. Foremost of these is the exciting addition of the novel agents ipilimumab and vemurafenib for treat...

Discussions